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Abstract
Background The NHS Diabetes Prevention Programme 
(NHS-DPP) has been delivered by four commercial or-
ganizations across England, to prevent people with im-
paired glucose tolerance developing Type 2 diabetes. 
Evidence reviews underpinning the NHS-DPP design 
specification identified 19 Behavior Change Techniques 
(BCTs) that are the intervention “active ingredients.” It 
is important to understand the discrepancies between 
BCTs specified in design and BCTs actually delivered.
Purpose To compare observed fidelity of delivery of 
BCTs that were delivered to (a) the NHS-DPP design 
specification, and (b) the programme manuals of four 
provider organizations.
Methods Audio-recordings were made of complete de-
livery of NHS-DPP courses at eight diverse sites (two 
courses per provider organization). The eight courses 
consisted of 111 group sessions, with 409 patients and 35 
facilitators. BCT Taxonomy v1 was used to reliably code 
the contents of NHS-DPP design specification docu-
ments, programme manuals for each provider organiza-
tion, and observed NHS-DPP group sessions.
Results The NHS-DPP design specification indicated 19 
BCTs that should be delivered, whereas only seven (37%) 
were delivered during the programme in all eight courses. 
By contrast, between 70% and 89% of BCTs specified in 
programme manuals were delivered. There was substan-
tial under-delivery of BCTs that were designed to improve 
self-regulation of behavior, for example, those involving 
problem solving and self-monitoring of behavior.
Conclusions A lack of fidelity in delivery to the underlying 
evidence base was apparent, due to poor translation of 
design specification to programme manuals. By contrast, 
the fidelity of delivery to the programme manuals was 
relatively good. Future commissioning should focus on 
ensuring the evidence base is more accurately translated 
into the programme manual contents.
Keywords:  Type 2 diabetes · Diabetes prevention pro-
gramme · Nondiabetic hyperglycemia · Intervention fi-
delity · Behavior change · Behavior change techniques
Introduction
In response to the increasing incidence of Type 2 diabetes, 
prevention programmes have been implemented inter-
nationally, which target individuals at increased risk of 
developing Type 2 diabetes due to nondiabetic hypergly-
cemia. Across multiple countries, trials have found such 
programmes to be effective at promoting weight loss and 
thereby reducing the risk of developing Type 2 diabetes 
[1]. In line with this, the first wave of the National Health 
Service Diabetes Prevention Programme (NHS-DPP) 
was implemented across England in 2016, following a 
pilot phase in several “demonstrator” sites [2]. The first 
wave of national NHS-DPP rollout was implemented 
with four different commercial provider organizations 
delivering their own versions of the NHS-DPP, based on 
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the NHS design specification. This design specification 
consisted of an NHS-DPP service specification, which 
described features of prevention programmes to which 
each provider organization should adhere, for example, 
at least 13 sessions over a period of at least nine months 
[3], supplemented by the National Institute for Health 
and Care Excellence (NICE) public health 38 (PH-38) 
guidance “Type 2 diabetes: prevention in people at high 
risk” [4].
A key feature of  the NHS-DPP design specification 
was that it identified 19 Behavior Change Techniques 
(BCTs) that each provider organization’s version of  the 
NHS-DPP should deliver, across the NHS-DPP service 
specification [3] and NICE PH38 [4] documents. BCTs 
have been defined as the “active ingredients” of  inter-
ventions to change behavior, for example, setting goals 
regarding intended levels of  physical activity [5]. These 
have been precisely defined using a standard descrip-
tion of  93 such BCTs [5]. The NHS-DPP design spe-
cification was developed following a systematic review 
of  behavior change interventions to prevent diabetes 
that could be delivered in routine practice [6]. This sys-
tematic review did not draw clear conclusions around, 
which BCTs to include, as the direct evidence base for 
which specific BCTs were associated with greater ef-
fectiveness for this specific population was limited [6]. 
Planned moderator analyses exploring this issue were 
not informative due to most interventions containing 
the same BCTs [6]. Given this, the NHS-DPP design 
specification included the BCTs identified by the NICE 
PH38 guidance [4] as well as those specifically identi-
fied in the NHS service specification document [3]. This 
NICE guidance which was informed by a review of  sys-
tematic reviews with comparable populations. These 
systematic reviews identified BCTs that have found to 
be particularly effective at changing the key behaviors 
of  physical activity, healthy eating, smoking cessation, 
alcohol reduction, and sleep [4].
Early evaluation of the programme highlighted 
concerns expressed in interviews with stakeholders in 
the NHS-DPP demonstrator sites about the extent to 
which the NHS-DPP provider organizations are in fact 
delivering the 19 BCTs that the NHS-DPP design spe-
cification indicate [7]. These stakeholders, including 
local commissioners and healthcare professionals who 
referred to the NHS-DPP, identified that procedures to 
ensure that BCTs were delivered as planned were unclear 
and relied on provider organizations verifying what was 
delivered, with no external validation. Any lack of de-
livery of the 19 BCTs specified is problematic for three 
main reasons. First, there was evidence that these BCTs 
are particularly effective at changing health-related be-
haviors [4]. Second, if  provider organizations are not 
delivering these BCTs, but instead are delivering other 
BCTs, it will be difficult to establish the reasons for the 
effectiveness of the NHS-DPP or lack of effectiveness, 
and thereby improve this programme [8]. Third, given 
that four provider organizations were delivering the 
NHS-DPP, it is important to be sure that a similar ser-
vice is being delivered by each provider organization.
It is generally agreed that it is useful to tailor or 
adapt programmes for each population that receives an 
intervention, for example, cultural adaptation of food 
recommendations [9]. Despite this, there is also gen-
eral agreement that the mechanisms of action of pro-
grammes should be the same following adaptation [10]. 
In the NHS-DPP, the mechanisms of action are those 
processes through which the 19 core BCTs are supposed 
to have their effect [11].
The issue of whether provider organizations are 
delivering BCTs that they were supposed to deliver is 
one aspect of intervention fidelity [8]. Although various 
frameworks for intervention fidelity are available, a 
leading model is that proposed by the National Institutes 
of Health Behavior Change Consortium [8]. This model 
distinguished between five aspects of fidelity: (a) the de-
sign of the intervention, that is, what was planned to be 
delivered, (b) training for those facilitators delivering the 
intervention, (c) delivery of the intervention, (d) inter-
vention receipt, that is, how the intervention is under-
stood and experienced, and (e) intervention enactment, 
that is, whether people who receive the intervention carry 
out the activities that the intervention is designed to 
stimulate. The issue of intervention fidelity has attracted 
a good deal of research, but much of it focuses on fi-
delity of delivery to the detriment of other aspects [12].
Previous fidelity research on the NHS-DPP has thor-
oughly mapped out intervention design [13]. This research 
identified the core 19 BCTs in the NHS-DPP design spe-
cification, through mapping of BCTs in the NHS-DPP 
service specification document [3] and the NICE PH38 
guidance [4]. It compared these BCTs with the interven-
tion designs for each of the four NHS-DPP provider or-
ganizations, consisting of each provider organization’s 
intervention programme manual and the framework re-
sponse documents [13]. The programme manuals are the 
documents that are used by facilitators throughout the 
programme, and consists of a “cookbook” describing 
what BCTs should be delivered in the intervention, how 
they should be delivered, and how frequently (i.e., what 
“dose” of each BCT). Framework response documents 
were required by NHS England from each of the four 
provider organizations during the 2016 commissioning 
process A  section of these framework response docu-
ments detailed their proposed service delivery (including 
underlying theory and inclusion of BCTs), in line with 
NHS England requirements. Thus, this previous re-
search compared two aspects of intervention design: 
that proposed by NHS England (the NHS-DPP design 
specification) and that proposed by the four commercial 
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provider organizations (their intervention designs). This 
comparison showed that the four provider organizations 
each planned to deliver 14 of the 19 BCTs included in the 
NHS-DPP design specification, although the 14 BCTs 
varied between provider organizations [13]. Further, the 
four provider organizations’ programme manuals con-
tained a further nine to 31 BCTs not included in the 
NHS-DPP design specification [13]. Thus, there was a 
lack of fidelity to the NHS-DPP design specification in 
each provider organization’s planned intervention design.
The present research extends this earlier research, 
aiming to examine what BCTs were actually delivered 
by NHS-DPP facilitators when delivering the full NHS-
DPP courses (see Fig. 1 for a schematic that shows the 
aspects of fidelity considered in the present study: NHS-
DPP design specification, provider intervention design, 
and intervention delivery).
The present research also considers the dose of the BCTs 
delivered, in terms of both providers’ intervention designs 
and actual delivery. Dose can be considered in relation to 
duration, frequency, and total amount, which is a func-
tion of duration and frequency [14]. The present research 
considers dose in relation to frequency (i.e., the number of 
times a BCT was delivered), as each provider organization 
specified a frequency in their programme manuals, thereby 
allowing a direct comparison with the frequency of delivery. 
There is little guidance currently on what is the optimal dose 
of an intervention [14], so a comparison of whether the 
dose specified by provider organizations in their programme 
manuals and in actual delivery was a fair comparison, as 
the providers themselves indicated what would be an appro-
priate dose when they wrote the programme manuals.
Given that it was not possible to identify frequency 
of BCTs in the provider organizations’ framework re-
sponses, the present research only looked at the pro-
gramme manuals when considering dose. Similarly, a 
comparison of fidelity of delivery of dose with NHS-
DPP design specification is not possible, as this specifica-
tion did not indicate a dose either. The present analyses 
report fidelity of delivery of BCTs in relation to pres-
ence/absence and to dose of the provider organizations’ 
programme manuals for three reasons. First, the provider 
organizations’ programme manuals were considered to 
be the best description of what BCTs were intended to 
be delivered, as these were directly used in intervention 
delivery. Second, there was little additional information 
on BCTs at all in framework responses compared to 
programme manuals. Third, the reporting of fidelity to 
programme manuals for both presence/absence and dose 
facilitated comparisons between these two indices of fi-
delity. However, to ensure that the decision to consider 
just programme manual and not framework responses in 
relation to provider organizations’ intervention designs, 
sensitivity analyses were conducted to examine the ef-
fects of these analytic choices on results obtained.
Thus, specific objectives of the present analyses were:
 a.  To describe which BCTs were delivered, with 
what frequency for each of the four provider 
organizations;
 b.  To compare whether the BCTs that were de-
livered had fidelity to those BCTs in both the 
(i) NHS-DPP design specification, and the (ii) 
programme manuals of each of the four NHS-
DPP provider organizations;
 c.  To assess whether the dose of BCTs being de-
livered had fidelity to the dose indicated in the 




Delivery of the complete NHS-DPP course was ob-
served at two sites per provider organization, to yield 
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Fig. 1. Schematic showing aspects of intervention fidelity assessed in present study.
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assessments where patients were offered participation in 
the NHS-DPP were not included, as the NHS-DPP ser-
vice specification indicates that the intervention starts 
with the first group session [3]. This delivery was com-
pared with two indicators of the design of the NHS-DPP 
programme, described earlier [13]:
 1. The NHS-DPP design specification, derived by 
coding the service specification documents produced 
for the commissioning process [3], including NICE 
PH38 guidance for prevention of Type 2 diabetes in 
people at high risk [4].
 2. The planned intervention design for each NHS-DPP 
provider organization was identified based on coding 
of each of the providers’ programme manuals [13].
Participants and Setting
Written consent was obtained for everyone present in the 
NHS-DPP course sessions observed, including the fa-
cilitators delivering the programme, patients, and family 
members/carers accompanying patients.
The NHS commissioned four commercial provider 
organizations to deliver the DPP, to facilitate the prob-
lems of implementing a national programme at scale in 
a short time frame. Three of the providers were national 
organizations who deliver a range of programmes for 
health, wellbeing, and employment (i.e., Ingeus, ICS, 
and Reed Momenta), and one of the providers was a 
nonprofit organization (LWTC). We have not named 
the providers in the present report, as a condition of the 
present research was that we would not link findings to 
specific providers. For each provider organization, the 
intervention was delivered in line with NHS England’s 
stipulation of delivery in groups of no more than 15–20 
adults with non-diabetic hyperglycemia, over at least 13 
sessions [3]. Further details on participants, provider set-
ting and facilitators is provided in Table 1.
Procedure
NHS ethical approval for the study described in the 
manuscript was granted by the North West Greater 
Manchester East NHS Research Ethics Committee (ref. 
17/NW/0426, August 1, 2017).
Sites were purposively sampled based on an overall 
sampling frame of NHS-DPP providers that were in 
place during the first wave of national rollout in 2018–
2019. The term “site” refers to the geographical location 
in which observations took place. We aimed to sample 
sites with variation in geographical location, deprivation, 
and ethnicity. Observations of more than one group co-
hort at sites was required in some cases (see Table  1), 
with the aim of sampling group cohorts for the same 
provider organization as similar as possible to the ori-
ginal group cohorts. Resampling was required due to (a) 
provider organization delays in scheduling maintenance 
sessions for some cohorts (k = 4 sites), and (b) some par-
ticipants attending the first session, but not providing 
written consent, so the first session had to be observed 
at different sites delivered by the same provider organiza-
tion (k = 3 sites). In addition, some cohorts merged due 
to participant dropout (k = 3 sites). Observations were 
undertaken between August 2018 and November 2019.
Written consent was obtained on the first day that 
researchers were present at the group (usually Session 
1), prior to the session commencing. Participants pro-
vided written consent on first meeting researchers, and 
this consent carried over to future NHS-DPP sessions in 
which researchers were present. At the beginning of each 
subsequent session, researchers checked that everyone 
present had previously provided consent. If  a new pa-
tient was attending the group session, full written con-
sent was obtained before recording.
Delivery of BCTs was captured via an audio recorder 
being placed next to the facilitator during both group 
sessions and sessions, which included one-to-one con-
sultations with patients.
Analysis
Audio recordings were transcribed verbatim by an ex-
ternal transcription company. Researchers used both the 
audio recordings and transcripts to code BCT delivery, 
supplemented by contemporaneous notes. The use of 
audio recordings allowed information from tone of voice 
and speech to be used when coding. The contemporan-
eous notes documented any observations that may not 
have been picked up on the audio recorder, for example, 
handing out worksheets, any issues observed in the ses-
sion, and so on. The audio recordings and notes some-
times gave additional context to the transcripts.
BCTs were extracted onto a coding sheet developed 
for the present study. The standardized 93-item BCT 
taxonomy (BCTT) v1 was used [5], and researchers 
underwent training in its use developed by the taxonomy 
authors [15]. Two further BCTs were used. The BCT 
of “increase positive emotions” is not included in the 
BCTTv1, but was noted by the BCTTv1 authors for in-
clusion in the next version of the taxonomy. The BCT 
“increase salience of behaviors” was not listed in the 
BCTTv1, but was previously identified as being speci-
fied by each of the four NHS-DPP provider organiza-
tions [13]. Definitions of both BCTs appear in footnotes 
in Tables 2 and 3.
A set of  coding rules were developed (see 
Supplementary S1), which were based on the same 
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coding rules previously used to code the documents 
describing NHS-DPP design [13]. A discrete instance 
of  each BCT was considered present on the com-
mencement of  a new activity or if  a different health 
behavior (e.g., diet, physical activity) was targeted, to 
allow coding of  the “dose” or number of  times each 
BCT was delivered, as well as whether it was present 
or not. The programme manuals identified “activities,” 
which included problem solving discussions, filling 
out worksheets, providing information, and so on. 
Researchers coded every individually delivered BCT 
captured on the audio-recording, but when collating 
the number of  BCTs delivered in that session, where 
the same BCT was delivered to different attendees 
during their one-to-one reviews, that BCT was only 
counted as occurring once. A  single researcher inde-
pendently coded all 111 sessions, and 16 sessions (14%) 
were double coded (two sessions per site) to allow as-
sessment of  reliability of  coding. Any discrepancies in 
coding were discussed by these researchers until agree-
ment was met. Researchers documented reasons why 
a BCT was coded or not in the relevant BCT coding 
sheet. The reasons were in line with BCTTv1 guid-
ance, e.g. the BCT “problem solving” was not coded 
where barriers were discussed, but not solutions to the 
barriers; or the BCT “social support unspecified” not 
coded as the activity was not linked to the performance 
of  a behavior. To assess agreement in whether a BCT 
was present or not between the whole programme de-
sign and delivery, percentage agreement, and Cohen’s 
kappa coefficient were used [16]. To assess agreement 
on dose of  BCTs (i.e., number of  BCTs) between 
whole programme design specifications and delivery, 
Spearman’s rho statistic was used.
Two sensitivity analyses were conducted, to assess 
whether the decisions regarding how to operation-
alize provider intervention designs affected the results 
obtained. First, the specification of what should be de-
livered was broadened to also include BCTs that were 
included in the provider organizations’ framework re-
sponse documents, but not necessarily indicated as com-
pulsory in providers’ programme manuals. In the second 
sensitivity analysis, the specification of what should be 
delivered was broadened to also include BCTs that were 
indicated as “optional” in programme manuals.
Results
Complete delivery of the NHS-DPP was observed for 
two sites for each of the four provider organizations. 
Across the eight sites, 18 cohorts were recruited (see 
Table 1), due to some cohorts merging due to dropout, 
provider organization delays in scheduling maintenance 
sessions and it not being possible to obtain consent for 
all people present. In these eight sites, 111 group sessions 
were observed, with a total of 35 facilitators, 390 NHS-
DPP participants, and 19 other carers or relatives (see 
Table 1). The sites were generally in locations that were 
relatively deprived for England, with seven of eight sites 
having indices of multiple deprivation (IMD) of three or 
below [17], and with substantial variation in the propor-
tion of people at each site who were white based on IMD 
(from 45% to 96% white) [18].
Which BCTs were Delivered?
The frequency with which each BCT was delivered was 
reliably coded, with Cohen’s kappa statistics from 0.56 
to 0.95 across the 16 sessions coded, with a mean of 
0.77. Of these 16 kappa statistics, two were at the top 
end of  the “moderate agreement” category (0.41–0.60), 
seven indicated “substantial agreement” (0.61–0.80) and 
seven indicated “perfect agreement,” according to con-
ventional criteria [16]. These Cohen’s kappa statistics 
were comparable for those produced for coding of  each 
of  the four design specification documents, from 0.75 to 
0.88 [13].
The number of times each BCT was delivered in each 
site over the whole programme is shown in Table  2. 
Definitions of all BCTs is provided in Supplementary S2, 
along with example codes. Across the sites, the most com-
monly delivered BCTs were “information about health 
consequences” (delivered 554 times), “social support 
[unspecified]” (delivered 128 times), “behavior substitu-
tion” (delivered 118 times), “feedback on outcome(s) of 
behavior” (104 times), and “self-monitoring of behavior” 
(delivered 86 times).
Were the BCTs that were Delivered Indicated in the 
NHS-DPP Design Specification?
The 19 BCTs indicated in the NHS-DPP design speci-
fication were generally among the most commonly de-
livered BCTs (see Table 2). For the eight sites observed, 
between 9 and 13 of the specified 19 BCTs were delivered 
across whole programme (shown in Table 2). Of these 19 
BCTs, only seven BCTs were delivered at all eight sites 
during the whole delivery of the NHS-DPP. Three of the 
BCTs were not delivered at any site at any point in the 
programme, that is, “social support (emotional),” “pros 
and cons,” and “monitoring of outcome(s) of behavior 
without feedback.”
In addition to the 19 BCTs indicated in the NHS-DPP 
design specification, a further 33 BCTs were delivered 
at one or more sites. Of these 33 BCTs, seven were de-
livered at all sites (37% of 19 BCTs), including “feedback 
on outcome(s) of behavior,” which was the BCT that 
was delivered fourth most frequently. Each site delivered 
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between 15 and 25 additional BCTs that were not in-
cluded in the NHS-DPP design specification. Given the 
low rates of delivery of specified BCTs, and high rates of 
delivery of nonspecified BCTs, the agreement statistics 
between BCTs included in NHS design specification and 
what was delivered ranged from κ  =  0.22 to κ  =  0.37 
across the eight sites. This extent of agreement is con-
sidered “fair” according to conventional criteria [16].
Table 2. Behavior change techniques specified in the NHS-DPP programme design specification compared to frequency of behavior 
change techniques delivered across whole course in each of eight sites
Behavior change  
techniques
NICE PH38 NHS 
spec.
Provider A Provider B Provider C Provider D
Site A1 Site A2 Site B1 Site B2 Site C1 Site C2 Site D1 Site D2
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Were the BCTs that were Delivered Indicated in the Four 
Provider Programme Manuals?
The four provider organizations included between 20 and 
43 mandatory BCTs in their programme manuals [13]. 
At each of the eight sites, the majority of these BCTs 
were delivered during the programme (see Table 3). The 
proportion delivered ranged from 14/20 (70%) [Site D1] 
to 24/27 (89%) [Site A1]. Apart from the BCTs indicated 
in the programme manuals, each site delivered some 
Table 3. Frequency of behavior change techniques specified in each providers’ programme manuals compared to frequency of behavior 
change techniques delivered across whole course in each of eight sites
Behavior Change  
Techniques
PA Site A1 Site A2 PB Site B1 Site B2 PC Site C1 Site C2 PD Site D1 Site D2
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additional BCTs, with this number of BCTs ranging 
from two additional BCTs (Sites C1 and C2) to 11 (Site 
D1).
The agreement statistics between BCTs included in 
programme manuals and what was delivered ranged 
from κ = 0.50 (Site D1) to κ = 0.78 (Site C1) across the 
eight sites. This extent of agreement is considered “mod-
erate” for the two provider D sites [16], where the number 
of BCTs not included in programme manuals (9 and 11 
for Sites D2 and D1 respectively) approached the number 
that were included (15 and 14 respectively). Agreement 
was “substantial” for the six other sites [16].
Sensitivity analyses showed that the agreement statis-
tics between BCTs in the provider intervention designs 
and actual delivery were robust to how the provider 
intervention designs were operationalized. First, where 
the specification of what should be delivered was broad-
ened to also include BCTs that were included in the pro-
vider organizations’ framework response documents as 
well as programme manuals (see Supplementary S3), the 
agreement statistics between design and delivery were 
slightly lower at all eight sites than in the main analysis, 
and ranged from κ = 0.45 (Site D2) to κ = 0.76 (Site C1). 
Second, when the specification of what should be de-
livered was broadened to also include BCTs that were 
indicated as “optional” in programme manuals as well as 
mandatory BCTs (see Supplementary S4), the agreement 
statistics between design and delivery were very similar 
to those in the main analysis, and ranged from κ = 0.50 
(Site D1) to κ = 0.79 (Site C1).
What is the Dose of BCTs being Delivered, and is this 
In Line with the Dose Indicated in the Four NHS-DPP 
Provider Programme Manuals?
The programme manuals for the four provider organ-
izations indicated between 126 (Provider D) and 395 
(Provider C) total instances of BCTs should have been 
delivered (see Table  3). There was generally strong 
agreement between the number of times each BCT was 
delivered and the number of times that programme man-
uals indicated that BCT should be delivered (see Table 3). 
Spearman’s rho for the eight sites ranged from rs = 0.46 
(Site D1) to rs = 0.83 (Site A1).
The BCT that was most under-delivered was “problem 
solving,” delivered 128 times fewer than indicated in the 
programme manuals, followed by “self-monitoring of 
behavior” (under-delivered 58 times) and “review out-
come goal(s)” (under-delivered 55 times). By contrast, 
“feedback on outcome(s) of behavior” was delivered 58 
times more than the programme manuals indicated that 
it should have been, followed by “behavior substitution” 
that was delivered 53 times more than the programme 
manuals indicated.
Discussion
There was a substantial gap between the BCTs indicated 
in the NHS-DPP design specification to those actually 
delivered in the whole NHS-DPP courses at the eight 
sites observed. Only seven of the specified 19 BCTs were 
delivered at all sites. Across the eight sites, between 15 
and 25 BCTs were delivered that were not included in 
the NHS-DPP design specification. It is notable that the 
four providers generally delivered those BCTs specified 
in their programme manuals, with between 70% and 89% 
of the planned BCTs being delivered during the courses 
across the eight sites observed. The dose of BCTs being 
delivered was also generally in line with dose specified 
in programme manuals. There was extensive delivery of 
some BCTs, notably providing information about health 
consequences, but underdelivery of others compared with 
what was specified in provider programme manuals, not-
ably those involving problem solving, self-monitoring of 
behavior, and reviewing outcome (typically weight) goals.
A key strength of  the present research is that it exam-
ined the fidelity of  a programme where the research 
team were independent of  the teams that developed the 
intervention. Examination of  intervention fidelity by 
people who were not involved in its development is rare 
[19]. Other strengths of  the present study include the 
elicitation and coding of  all key documents for NHS-
DPP design specification and provider intervention 
design, including commercially sensitive programme 
manuals. Further, the present study observed com-
plete delivery of  the NHS-DPP at eight sites, involving 
35 facilitators being observed at 111 sessions. Design 
specifications of  NHS-DPP and providers, and obser-
vations of  delivery were reliably coded using standard-
ized methods.
Clearly, eight sites cannot be truly representative of 
an entire programme, but the present approach aimed 
to ensure that the research captured in depth what was 
delivered in complete courses, within the constraints of 
time and resource. Further, there were two cohorts ob-
served for each provider organization, which indicated 
consistency within providers. A  limitation that applies 
to nearly all research observing the delivery of interven-
tions is that the facilitators were aware that they were 
being observed. However, the evidence on the effects of 
reactivity to being measured or observed suggests that 
such effects are typically fairly transitory [20], and if  
present, the present research would provide an overesti-
mate of fidelity of delivery. A final limitation is that the 
present analysis focused only on the design and delivery 
of the NHS-DPP with regard to BCTs. We did not con-
sider other aspects of intervention design and delivery 
that contribute to intervention success, such as therapist 
warmth and therapeutic alliance [21].
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It has previously been shown that each provider 
planned to deliver 74% of the unique BCTs in the NHS-
DPP specification, and a large number of BCTs, which 
were not specified [13]. The present research builds on 
this earlier finding to show a substantial gap from NHS-
DPP design specification to what was delivered for all 
four providers, highlighting a lack of fidelity to the ori-
ginal evidence base for the NHS-DPP programme [3, 4, 
6]. Importantly, the gap between what providers planned 
to deliver (as indicated by their programme manuals) and 
what they actually delivered was comparatively small.
To our knowledge, this is the first thorough examin-
ation of fidelity of delivery to design specification for 
any diabetes prevention programme in the world. It is 
generally very rare for there to be empirical examination 
of fidelity of delivery of any intervention not developed 
by a study team [19], such as with the NHS-DPP, and 
particularly where there were multiple providers, such as 
in the present case. The most comparable examination 
would be the examination of national Stop Smoking 
Services in England, where 63% of planned BCTs based 
on programme manuals were delivered in face-to-face 
[22] and 42% were delivered in telephone sessions [23]. 
The NHS-DPP compares favorably with 82%–91% de-
livery of planned BCTs across the eight sites (shown in 
Table 3). Such high levels of fidelity of delivery of BCTs 
to programme manuals are rarely found in interventions 
not delivered by a research team [24]. The NHS-DPP 
also compares favorably in terms of not delivering BCTs 
that were not in programme manuals, with the range of 
4%–15% across the eight sites (shown in Table 3) being 
substantially lower than the 65% of unplanned BCTs 
delivered in face-to-face and 23% delivered in telephone 
sessions found in the Stop Smoking studies [22, 23].
Although many other studies have examined fidelity 
of delivery of behavior change interventions, often in 
relation to BCTs, the quality of the fidelity assessment 
observed is likely to be typically lower than the fidelity 
studies just mentioned, where the research team did not 
deliver the intervention and the intervention was de-
livered as scale. For example, systematic reviews of be-
havior change interventions have found that objective 
assessment of delivery was rare, and methods were often 
of uncertain reliability [25, 26]. For this reason, calls for 
greater validity in fidelity assessment have repeatedly 
been made [12, 26]. Given this, it may not be useful to 
compare findings of these studies to the present study.
It is notable that there was underdelivery of other 
BCTs, notably those involving problem solving, self-
monitoring of behavior, and reviewing outcome (typic-
ally weight) goals. These latter BCTs aim to improve the 
capability of participants to self-regulate their behavior. 
Importantly, although outcome (weight) measure-
ment frequently happened in the intervention sessions 
and were fed back to participants, they were not often 
reviewed with participants so they could modify their 
goals in light of failure or success. Similar underdelivery 
of self-regulation techniques such as goal setting and 
action planning has been noted in other studies [27]. 
Other BCTs that were underdelivered by all providers 
were those that involved monitoring behavior such as via 
diaries or pedometers without feedback, prompting con-
sideration of pro’s and con’s, and providing emotional 
social support. The underdelivery of all these BCTs pre-
sents the greatest opportunity for improvement, given 
that the evidence review underpinning the NHS-DPP 
flagged up such BCTs as important [4], in line with evi-
dence from the wider literature on the effectiveness of 
self-regulation BCTs [28].
There was evidence of overdelivery of BCTs that are 
easier to deliver, notably providing information about 
health consequences. It was particularly notable that be-
tween 15 and 25 BCTs not included in the NHS-DPP de-
sign specification were delivered at the eight sites, with a 
total of 33 distinct BCTs being added to the 19 that the 
NHS-DPP design specified. There are two implications 
of the delivery of these additional BCTs. First, there is 
evidence from some reviews that interventions that in-
clude more BCTs produce larger changes in behavior than 
interventions with fewer BCTs [29]. Thus, the inclusion of 
these additional BCTs may therefore be useful. However, 
the evidence base is stronger for BCTs included in the 
NHS-DPP design specification, so the beneficial effects 
of these additional BCTs will probably be outweighed 
by the harmful effects of not including the BCTs in the 
NHS-DPP specification. A further implication of the in-
clusion of these additional BCTs is that it resulted in sub-
stantial variation in what is being delivered by the four 
provider organizations. Thus, although the NHS-DPP is 
a nationally implemented programme, there appears to 
be differences in what BCTs patients receive according to 
which provider organization they are allocated. It is cur-
rently unclear whether there are differences in effective-
ness due to provider organization [30].
The authors of the present work are conducting sev-
eral other streams of work in relation to fidelity of the 
NHS-DPP, which are intended to shed light on the find-
ings reported here. First of all, an analysis of mode 
of delivery, including number of sessions, length of 
sessions, and provider characteristics has been made [31], 
which indicates that there is good fidelity of NHS-DPP 
delivery to these organizational and structural aspects. 
Other work has observed the training of the intervention 
facilitators, and found that facilitators were not trained 
in all BCTs noted in provider intervention design speci-
fications [32]. This may provide at least a partial explan-
ation for the discrepancies between design and delivery 
noted here. Ongoing qualitative work is examining how 
the intervention is received, an under-researched aspect 
of fidelity [12]. This examination of receipt may shed 
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light on how the additional BCTs that providers have in-
cluded were received, as well as issues such as the relative 
importance of BCT content compared to other aspects 
of the intervention, such as structural issues or facili-
tator characteristics.
Future research could usefully examine the relative 
impacts of  the four programmes on participant experi-
ence and behavior change. The substantial variation 
between provider organizations offers a useful natural 
experiment at scale from which researchers should 
profit. The best available evidence based on analyses by 
the NHS-DPP team [30] suggests that the NHS-DPP 
is having an effect on weight loss (2.3 kg) and HbA1c 
(1.26 mmol/mol) in intention-to-treat analysis. The pre-
sent analysis suggests there is room for the NHS-DPP 
to improve these outcomes in future iterations, given the 
underdelivery of  self-regulatory BCTs that the wider lit-
erature on behavior change suggest are key to effective 
behavior change. Consideration of  relative effectiveness 
on key outcomes between provider organizations would 
provide a more compelling evidence base for precisely 
which BCTs are most useful in terms of  changing these 
outcomes, particularly with regard to those BCTs that 
are not specified in the evidence base, and which vary 
between providers. A  final area where more research 
would be useful would be to interview facilitators or 
other provider organization staff  to get a clearer in-
sight into why BCT delivery was not more in line with 
provider intervention designs or the NHS-DPP design 
specifications.
The key implication of these findings is that there is 
a need for commissioners of national interventions put 
greater effort into ensuring provider organizations use 
BCTs for which there is the strongest evidence. The pre-
sent research has shown that delivery of BCT content 
that is contained within programme manuals is very 
good. However, there appears to be a gap between what 
the evidence base suggests and delivery, largely because 
of failures to translate the evidence base into manualized 
form by all four provider organizations [13]. Thus, fo-
cusing efforts on ensuring the evidence base translates 
into the contents of programme manuals in future rounds 
of commissioning appears warranted. It would be useful 
to examine how best NHS-DPP commissioning and 
monitoring arrangements can improve fidelity of BCT 
delivery in future NHS-DPP commissioning rounds, as 
this would likely have much wider applicability.
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